-
ARE WE MAKING THE RIGHT COMPARISONS? EXAMINING THE WILLINGNESS-TO-PAY THRESHOLD UNDER DIFFERENT PERSPECTIVES
Mar 18, 2026, 21:38 PM -
SOCIAL MEDIA CONVERSATIONS ON GLP-1 THERAPIES FOR OBESITY: REAL-WORLD EXPERIENCES AND TREATMENT NARRATIVES
Mar 18, 2026, 21:38 PM -
COMPARATIVE RISK OF SUICIDAL IDEATION AND SELF-HARM AMONG PATIENTS WITH MAJOR DEPRESSIVE DISORDER TREATED WITH BREXPIPRAZOLE VERSUS OTHER ORAL ATYPICAL ANTIPSYCHOTICS: A PROPENSITY SCORE-MATCHED COHORT ANALYSIS
Mar 18, 2026, 21:38 PM -
SOCIODEMOGRAPHIC AND COMORBIDITY FACTORS INFLUENCE MASLD RISK IN TYPE 2 DIABETES
Mar 18, 2026, 21:38 PM -
THE CURRENT LANDSCAPE OF ARTIFICIAL INTELLIGENCE (AI) METHODOLOGY IN HEALTH ECONOMICS AND OUTCOMES RESEARCH (HEOR): A REVIEW OF ISPOR EUROPE 2025 ABSTRACTS
Mar 18, 2026, 21:38 PM -
NOVEL PATIENT-CENTERED APPROACH TO CLINICAL TRIAL READINESS IN RARE DISEASES
Mar 18, 2026, 21:38 PM -
ASSESSING ACCESS TO INNOVATIVE ORPHAN MEDICINES IN LATIN AMERICA: A CROSS-COUNTRY VALUE AND ACCESS ANALYSIS
Mar 18, 2026, 21:38 PM -
DEVELOPMENT OF AN ALGORITHM ESTIMATING CISPLATIN-BASED CHEMOTHERAPY INELIGIBILITY AMONG PATIENTS WITH MUSCLE-INVASIVE BLADDER CANCER USING REAL-WORLD DATA
Mar 18, 2026, 21:38 PM -
SCOPING REVIEW OF REMOTE PATIENT MONITORING SOLUTIONS USING SENSOR-BASED TECHNOLOGIES IN ONCOLOGY CARE
Mar 18, 2026, 21:38 PM -
COST-EFFECTIVENESS OF INAVOLISIB IN THE TREATMENT OF PIK3A-MUTATED, HR+/HER2-ABC LOCALLY ADVANCED OR METASTATIC BREAST CANCER IN THE US
Mar 18, 2026, 21:38 PM -
ASSESSING THE IMPACT OF INCLUSION OF PATIENTS WITH MISSING EASTERN COOPERATIVE ONCOLOGY GROUP (ECOG) PERFORMANCE STATUS IN REAL-WORLD OUTCOMES OF THIRD-LINE OR LATER (3L+) DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL)
Mar 18, 2026, 21:38 PM -
THE ROLE OF SURROGACY ANALYSIS IN US AND CANADIAN HEALTH TECHNOLOGY SUBMISSIONS: A THEMATIC AND TEMPORAL REVIEW
Mar 18, 2026, 21:38 PM -
QUALITY ASSESSMENT IN A SYSTEMATIC LITERATURE REVIEW USING AN ARTIFICIAL INTELLIGENCE MODEL
Mar 18, 2026, 21:38 PM -
INTEGRATING SOCIAL INNOVATION INTO MEDICAL EDUCATION: AN EVALUATION PROTOCOL FOR AFYA’S CLOWN THERAPY PROJECT
Mar 18, 2026, 21:38 PM -
ASSOCIATION OF SOCIAL DETERMINANTS OF HEALTH WITH RARE CANCER BURDEN IN THE UNITED STATES: A MEPS-BASED ANALYSIS
Mar 18, 2026, 21:38 PM -
DIGITAL HEALTH FOR HYPERTENSION IN RURAL NORTHERN NIGERIA: REAL-WORLD PATIENT-CENTERED AND ECONOMIC OUTCOMES FROM A MIXED-METHODS STUDY
Mar 18, 2026, 21:38 PM -
CLINICAL AND ECONOMIC BURDEN IN PEDIATRIC PATIENTS WITH SICKLE CELL DISEASE WITH RECURRENT VASO-OCCLUSIVE CRISES IN THE UNITED STATES
Mar 18, 2026, 21:38 PM -
A SYSTEMATIC REVIEW OF FINDINGS AND METHODS IN ECONOMIC EVALUATIONS OF DYADIC HEALTHCARE INTERVENTIONS
Mar 18, 2026, 21:38 PM -
COST-SAVINGS ASSOCIATED WITH VENETOCLAX-OBINUTUZUMAB VERSUS COVALENT BRUTON’S TYROSINE KINASE INHIBITOR IN FRONTLINE CHRONIC LYMPHOCYTIC LEUKEMIA: A REAL-WORLD STUDY
Mar 18, 2026, 21:38 PM -
SAFETY OF SEPIAPTERIN AND PEGVALIASE FOR THE TREATMENT OF PHENYLKETONURIA (PKU): A SIMULATED TREATMENT COMPARISON (STC)
Mar 18, 2026, 21:38 PM
